Aaron G.L. Fletcher
CIK 1789490 · last filed 2026-05-22
Aaron G.L. Fletcher is a corporate insider who has filed 40 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing, for ACTU, was dated May 22, 2026. Across all open-market trades the lifetime net is +$40.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions. 43 SEC filings were submitted jointly with BIOS Advisors GP, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.66M
7
40
$40.16M
Filer Profile
BOSTON, MA 02135
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTU | Director | 60,973 | $1.07 | $65.2K | $5.00M | 3 | 2026-05-22 |
| CGTX | Director | 475,155 | $0.98 | $467.0K | $2.28M | 2 | 2025-09-23 |
| AZTR | 10%+ Owner | 680 | $0.18 | $121 | $24.00M | 1 | 2023-06-23 |
| CUE | Director | 36,833 | $28.74 | $1.06M | $4.48M | 9 | 2023-01-05 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 10,123 | $0.07 | $658 | $4.40M | 11 | 2022-12-30 |
| SWK Holdings Corp (SWKH) Delisted | Director | 9,873 | $15.90 | $157.0K | $0 | 9 | 2022-01-12 |
| INAB | 10%+ Owner | 62,554 | $1.07 | $66.9K | $0 | 2 | 2021-08-17 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2025-09-23 | CGTX | Exer (M) | +7,729 | $6.5K | EDGAR |
| 2025-06-30 | ACTU | Buy (P) | +714,280 | $5.00M | EDGAR |
| 2025-05-23 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | AZTR | Mixed | +47,864,352 | $24.00M | EDGAR |
| 2023-01-05 | CUE | Grant (A) | — | $0 | EDGAR |
| 2022-12-30 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-23 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +43,470 | $50.0K | EDGAR |
| 2022-05-25 | CUE | Buy (P) | +205,000 | $711.7K | EDGAR |
| 2022-05-17 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +109,600 | $538.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.